Best Blood Collection Tubes for Plasma Testing: Heparin, EDTA, and Sodium Citrate Guide

Summary

• Heparin tubes are generally the first choice for routine plasma chemistry testing, while EDTA tubes are preferred for many molecular, hematology-related, and specialized assays.
• Sodium Citrate tubes are essential for coagulation studies because they preserve clotting factors and require an accurate 9:1 blood-to-Anticoagulant ratio.
• When purchasing phlebotomy supplies in the United States, laboratories should evaluate tube compatibility, manufacturer instructions, specimen stability, regulatory requirements, supply continuity, and total cost rather than relying on tube color alone.

Understanding Plasma and Why the Collection Tube Matters

Plasma is the liquid portion of anticoagulated blood. It contains water, electrolytes, proteins, hormones, nutrients, medications, clotting factors, and other substances used in laboratory diagnosis and monitoring. Unlike serum, plasma is obtained from blood that has been prevented from clotting before centrifugation. The Anticoagulant inside the collection tube determines which tests can be performed accurately.

Choosing a blood collection tube is therefore not simply a matter of selecting a convenient color or the lowest-priced product. The tube additive can affect electrolyte measurements, enzyme activity, coagulation results, drug concentrations, molecular testing, and the stability of the specimen during storage and transportation. A tube that is appropriate for one test can invalidate another.

In the United States, laboratories commonly purchase evacuated blood collection tubes from manufacturers that provide a range of tube sizes, additives, separator gels, draw volumes, closures, and sterility configurations. Products may look similar while having important differences in additive concentration, gel formulation, vacuum strength, expiration date, and compatibility with automated laboratory systems.

The best tube for a plasma sample depends on the intended test. For routine chemistry, lithium Heparin plasma is widely used. For coagulation testing, Sodium Citrate is the standard choice. For many molecular assays and selected specialized tests, K2EDTA plasma may be preferred. For glucose testing, fluoride-containing tubes may be appropriate when the laboratory method and specimen requirements call for them.

The Main Types of Plasma Collection Tubes

Heparin Tubes for Routine Plasma Chemistry

Heparin tubes are among the most broadly used tubes for plasma samples. They contain an Anticoagulant that inhibits thrombin formation and helps prevent clotting. Lithium Heparin is particularly common in clinical chemistry because lithium generally creates fewer analytical concerns than sodium Heparin when sodium concentration is being measured.

Green-top tubes traditionally contain Heparin, although color conventions are not universal. A green-top tube may contain lithium Heparin, sodium Heparin, or lithium Heparin with a plasma Separator Gel. Purchasers should always confirm the additive printed on the label and the manufacturer’s instructions for use rather than relying only on cap color.

Lithium-Heparin plasma is commonly used for tests such as basic metabolic panels, comprehensive metabolic panels, liver-function testing, renal-function testing, lipid testing, cardiac Biomarkers, and many therapeutic drug assays. It is also frequently selected for rapid-turnaround chemistry because plasma can often be processed sooner than serum. Serum specimens must clot before centrifugation, while properly collected heparinized specimens can generally proceed directly to processing.

Plasma separator tubes, often called PSTs, combine lithium Heparin with a polymer gel. During centrifugation, the gel forms a barrier between the plasma and cellular material. This can reduce cellular metabolism and help preserve the separation during transport. However, Separator Gel is not automatically appropriate for every test. Certain drugs, hormones, trace elements, and specialized analytes may adsorb to the gel or be affected by contact with it.

When purchasing Heparin tubes, laboratories should determine whether the Laboratory Information System, analyzer, and reference laboratory accept plasma separator tubes or require plain lithium-Heparin tubes. The laboratory should also confirm whether the gel is validated for the specific assays being performed.

EDTA Tubes for Molecular and Specialized Plasma Testing

EDTA tubes are commonly identified by lavender, purple, or pearl-colored caps. EDTA binds calcium, which is necessary for the clotting cascade. K2EDTA is widely used in evacuated blood collection tubes, while K3EDTA is used in some products and applications. K2EDTA is often preferred for many laboratory applications because it produces a lower dilution effect and may provide favorable hematology performance.

EDTA plasma is routinely used for certain molecular tests, viral-load assays, cell-free DNA testing, immunological assays, and specialized laboratory procedures. It may also be used when a laboratory protocol specifically calls for EDTA plasma instead of serum or heparinized plasma.

EDTA tubes are not suitable for many routine chemistry tests because EDTA contamination can significantly alter results. The additive can cause falsely increased potassium and falsely decreased calcium and magnesium. It may also interfere with alkaline phosphatase and other assays that depend on metal ions. Even a small amount of EDTA carryover can create a clinically significant error.

Plasma preparation tubes containing K2EDTA and a gel separator are available for certain applications. These tubes may be useful for molecular workflows, but the laboratory should verify whether the gel, tube material, and centrifugation protocol are approved for the assay. Cell-free DNA testing, for example, may require special stabilization tubes rather than conventional EDTA tubes, particularly when shipment or processing will be delayed.

Sodium Citrate Tubes for Coagulation Studies

Sodium Citrate tubes generally have light-blue caps and are the standard collection tubes for many coagulation tests. They are used for Prothrombin Time, International Normalized Ratio, Activated Partial Thromboplastin Time, fibrinogen, D-dimer, factor assays, and other hemostasis testing.

The defining feature of a citrate tube is its required blood-to-Anticoagulant ratio. The conventional ratio is nine parts whole blood to one part buffered Sodium Citrate. Because the ratio is critical, the tube must be filled to the marked volume. Underfilling creates excess citrate relative to plasma, which can falsely prolong clotting times. Overfilling can reduce the amount of Anticoagulant relative to blood and may also affect results.

For routine coagulation testing, a 3.2 percent Sodium Citrate concentration is widely used. A 3.8 percent formulation may be available, but laboratories must follow the specific requirements of their test methods and reference laboratories. These formulations should not be treated as interchangeable.

When collecting from patients with high hematocrit values, the amount of plasma in the specimen may be reduced. This can create an excessive citrate concentration even when the tube appears properly filled. Many laboratories use a hematocrit threshold, commonly above 55 percent, to determine whether citrate adjustment is required. The exact calculation and policy should be based on the laboratory’s validated procedure and applicable professional guidance.

Citrate tubes are not general-purpose plasma tubes. They should not be substituted for Heparin or EDTA tubes simply because all three contain anticoagulants. They are designed for a specific relationship between plasma, citrate, and coagulation testing.

Fluoride and Oxalate Tubes for Glucose Testing

Gray-top tubes often contain Sodium Fluoride, Potassium Oxalate, or another combination intended to inhibit glycolysis and preserve glucose. They may be selected for glucose, lactate, or related testing when immediate plasma separation is not possible and when the laboratory’s method specifies this type of specimen.

Sodium Fluoride does not stop glycolysis immediately. It mainly inhibits later stages of glycolysis, so collection and processing time remain important. For accurate glucose testing, laboratories should follow current specimen-handling recommendations, including prompt separation or use of a validated glycolysis-inhibiting tube.

Gray-top tubes are not appropriate for every glucose-related test. Some methods require serum, lithium-Heparin plasma, or a specialized stabilizing tube. For oral glucose tolerance testing, diabetes monitoring, and research protocols, the laboratory should confirm the required specimen type before purchasing large quantities.

Specialized Stabilization Tubes

Specialized blood collection tubes are available for applications such as cell-free DNA, circulating tumor DNA, RNA Stabilization, viral testing, and research Biobanking. These tubes may contain proprietary preservatives that stabilize nucleic acids or cellular components during transport.

Such tubes can be more expensive than conventional EDTA or Heparin tubes, but they may reduce processing requirements and improve Specimen Integrity when immediate centrifugation is unavailable. Their value depends on the Workflow. If a laboratory processes specimens within a short, validated time window, a standard tube may be more economical. If samples travel across multiple states or remain unprocessed for extended periods, a stabilization tube may reduce rejection and repeat-collection costs.

Purchasers should evaluate specialized tubes through a documented validation process. Important factors include allowable shipping temperatures, maximum time before processing, centrifugation requirements, compatibility with extraction instruments, and the stability of the target analyte.

How Tube Additives Affect Laboratory Results

Tube additives can influence results through several mechanisms. They may dilute the specimen, bind analytes, inhibit enzymes, alter pH, cause cellular changes, or introduce substances that interfere with the analytical method. The most common preanalytical errors include incorrect tube selection, underfilling, inadequate mixing, hemolysis, clotting, contamination from another tube, and delays in processing.

Tube inversion is important because it distributes the additive throughout the blood. Excessive shaking can cause hemolysis, while insufficient mixing can result in microclots or incomplete anticoagulation. The number of inversions varies by product, but many conventional evacuated tubes require gentle inversion rather than vigorous agitation. Staff should follow the manufacturer’s instructions for use and the laboratory’s standard operating procedure.

Hemolysis is a major concern because it releases intracellular substances into plasma. Potassium, lactate dehydrogenase, aspartate aminotransferase, and other analytes may be falsely elevated. Hemolysis can result from a small needle, excessive suction, forceful transfer, vigorous mixing, or difficult collection. Purchasing tubes with reliable vacuum performance and clear labeling can help, but proper technique remains essential.

Separator gels can improve Workflow but may create special considerations. Gel performance can vary with patient characteristics, centrifuge settings, temperature, and tube orientation during transport. Some analytes may partition into or interact with the gel. Laboratories should review the assay manufacturer’s instructions and local validation data before adopting gel tubes as a universal solution.

Recommended Tube Selection by Test Category

There is no single plasma tube that is best for every laboratory test. The following general framework can guide purchasing decisions, but the laboratory’s test directory and assay-specific instructions should take priority.

1. For routine chemistry and many metabolic tests, choose lithium-Heparin plasma, with or without a Separator Gel, when accepted by the analyzer and assay manufacturer.
2. For coagulation testing, choose properly filled 3.2 percent Sodium Citrate tubes and maintain the required blood-to-Anticoagulant ratio.
3. For many molecular, viral-load, and specialized plasma applications, choose K2EDTA tubes when specified by the assay or reference laboratory.
4. For glucose or lactate testing where glycolysis inhibition is required, choose a fluoride-containing tube or another validated stabilizing system.
5. For cell-free DNA, RNA, or other unstable targets, choose a specialized stabilization tube when the processing and transport schedule requires it.
6. For trace-element analysis, use tubes specifically certified for trace-metal testing because ordinary tube materials and additives may contribute contamination.
7. For Toxicology and Therapeutic Drug Monitoring, verify whether the method requires plastic, glass, serum, EDTA plasma, Heparin plasma, or a tube without Separator Gel.

What U.S. Buyers Should Check Before Ordering

Regulatory and Quality Documentation

In the United States, blood collection tubes used for clinical testing are generally regulated as medical devices. Buyers should review the manufacturer’s regulatory status, intended use, labeling, lot information, and instructions for use. Depending on the product and intended application, documentation may include FDA clearance or other applicable regulatory information.

Laboratories operating under the Clinical Laboratory Improvement Amendments should ensure that collection devices are suitable for the tests performed. Accreditation organizations such as the College of American Pathologists may inspect specimen collection, identification, handling, and processing procedures. The tube itself is only one part of the compliance system; staff training, documentation, Quality Control, and competency assessment are equally important.

Purchasers should request certificates of analysis or conformity when appropriate, lot-specific information, and evidence that the product meets relevant standards. Documents from organizations such as the International Organization for Standardization, the Clinical and Laboratory Standards Institute, and applicable U.S. regulatory agencies can support a more defensible purchasing decision.

Tube Size, Draw Volume, and Vacuum

Common blood collection tubes range from pediatric and low-volume formats to larger tubes designed for adult testing. A tube that is too large may waste blood and create an unnecessary burden for patients. A tube that is too small may not provide enough specimen for repeat analysis, reflex testing, or send-out requirements.

Vacuum strength matters because an under-drawing problem can affect the blood-to-additive ratio. This is particularly important for Sodium Citrate tubes. Pediatric and difficult-draw applications may require low-volume tubes with validated performance rather than partially filled standard tubes.

Before changing tube sizes, laboratories should compare minimum specimen volumes, instrument dead volume, aliquoting requirements, and the number of tests commonly ordered together. Reducing tube volume can improve patient comfort and reduce waste, but only if the laboratory can meet testing requirements reliably.

Compatibility With Equipment and Automation

Automated laboratories should verify tube compatibility with Pneumatic Tube Systems, centrifuges, decappers, aliquoters, analyzers, and storage systems. Differences in tube dimensions, cap design, label placement, gel behavior, or tube rigidity can disrupt automation.

Some analyzers recognize specific tube types through barcode rules or mechanical dimensions. A substitute tube may fit physically but fail to meet the analyzer’s validated specimen requirements. Before switching suppliers, the laboratory should conduct a formal evaluation that includes sample processing, barcode scanning, centrifugation, rack loading, aspiration, and storage.

Expiration Dates and Storage Conditions

Evacuated tubes have expiration dates because the vacuum, additive performance, gel properties, and closure integrity can change over time. Purchasing large quantities may lower the unit price but can increase waste if tubes expire before use.

Storage requirements may include limits on temperature, humidity, sunlight, and freezing. Tubes exposed to unsuitable conditions may experience reduced vacuum or additive degradation. A U.S. laboratory with multiple collection sites should establish minimum remaining shelf-life requirements at delivery and use a first-expire, first-out inventory system.

Cost Considerations When Purchasing Phlebotomy Supplies

Unit price is only one component of the total cost of a blood collection tube. A low-priced tube may create higher costs if it leads to Specimen Rejection, redraws, analyzer downtime, staff complaints, or incompatible workflows.

A useful purchasing analysis should include the following:

1. Unit price and volume discounts.
2. Freight, hazardous-material handling, and cold-chain charges when applicable.
3. Expiration-related waste.
4. Specimen Rejection and redraw rates.
5. Compatibility with current analyzers and automation.
6. Training required when changing tube types.
7. Validation and verification costs.
8. Supply interruption risk and emergency purchasing costs.
9. Recycling, disposal, and packaging requirements.
10. Customer service, technical support, and replacement policies.

For many laboratories, the cost of a redraw is substantially greater than the cost of a tube. A rejected specimen can require a second patient visit, additional phlebotomist time, new labels and supplies, transportation, delayed diagnosis, and possible treatment disruption. Consequently, a tube with a slightly higher purchase price may be economically preferable if it improves fill accuracy, reduces hemolysis, and performs reliably in the laboratory’s Workflow.

Health systems should also consider standardization. Using fewer tube types can simplify training and inventory management, but excessive standardization can be unsafe if it encourages an inappropriate tube for a particular assay. The best approach is usually a controlled tube menu tied to the laboratory test directory.

Supply Chain Planning in the United States

Recent disruptions in global manufacturing, transportation, plastics production, and medical-device distribution have demonstrated the importance of supply continuity. Blood collection tubes are high-volume consumables, and a shortage can quickly affect outpatient clinics, hospitals, physician offices, emergency departments, and reference laboratories.

U.S. buyers should avoid relying on a single product code when the test volume is high or the tube is clinically critical. A dual-source strategy may be appropriate, provided that both products are validated and available through approved distributors. However, switching between brands without verification can create problems because cap colors, additive concentrations, tube dimensions, and gel characteristics may differ.

Hospitals and independent laboratories should establish reorder points based on average daily use, lead time, seasonal demand, emergency demand, and supplier reliability. The inventory plan should account for holidays, weather events, public-health emergencies, and manufacturer back orders.

Barcode management is another important consideration. New tube suppliers may use different product identifiers, lot formats, and packaging quantities. Information technology and laboratory staff should update inventory systems and specimen-management rules before the new product reaches collection sites.

Validation Before Changing Tube Brands

A tube change should be treated as a controlled laboratory change, not merely a purchasing substitution. The required evaluation depends on the tube type, intended use, test menu, and accreditation policies.

A practical verification plan may include:

1. Reviewing the new tube’s instructions for use and intended specimen type.
2. Comparing additive concentration, draw volume, tube material, closure, and Separator Gel.
3. Identifying every assay that uses the current tube.
4. Testing specimens across relevant concentration ranges, including normal and abnormal samples.
5. Assessing hemolysis, clotting, fill volume, centrifugation, and specimen stability.
6. Confirming analyzer, aliquoter, barcode, and storage compatibility.
7. Documenting acceptance criteria before testing begins.
8. Training phlebotomists and updating collection manuals.
9. Monitoring rejection rates and analytical performance after implementation.

Coagulation tubes deserve special attention because fill volume and hematocrit can directly influence results. Molecular and cell-free DNA tubes may require separate stability studies. Gel tubes should be evaluated for analyte-specific interference, especially when the laboratory performs specialized testing.

Common Purchasing and Collection Mistakes

Choosing by Cap Color Alone

Cap colors are useful visual cues, but they are not a universal regulatory language. Colors can vary among manufacturers and regions. A green cap may contain lithium Heparin or sodium Heparin. A pearl cap may contain EDTA and gel, while another manufacturer may use a different color for a similar product. Always confirm the additive and intended use on the label.

Using EDTA Plasma for Chemistry Tests

EDTA contamination can produce major analytical errors, particularly for potassium, calcium, magnesium, and alkaline phosphatase. Collection staff should follow the approved order of draw and avoid transferring blood between tubes unless a validated procedure specifically permits it.

Underfilling Citrate Tubes

Underfilled light-blue tubes are a frequent source of coagulation problems. If the required blood volume cannot be obtained, the specimen should be handled according to the laboratory’s rejection and recollection policy. Simply sending an underfilled tube for testing may produce unreliable results.

Assuming Gel Tubes Are Suitable for Every Assay

Separator Gel tubes are convenient, but they are not universally interchangeable with plain tubes. Laboratories should verify compatibility for drugs, hormones, trace elements, Toxicology tests, and specialized proteins.

Ignoring Processing Time

Anticoagulation does not make a specimen stable indefinitely. Cells continue to consume glucose, release intracellular substances, and alter pH. Plasma should be separated, stored, and transported according to test-specific requirements.

A Practical Purchasing Decision

For a typical U.S. hospital or outpatient laboratory, lithium-Heparin plasma separator tubes are often the most versatile option for routine plasma chemistry. They can support rapid processing and are widely accepted by chemistry analyzers. However, they should not replace Sodium Citrate tubes for coagulation testing, K2EDTA tubes for assays that require EDTA plasma, or specialized stabilization tubes for delayed molecular workflows.

The most effective purchasing strategy is to build a test-to-tube matrix. Each test should list the accepted specimen type, preferred tube, alternate tube if validated, minimum volume, processing time, storage temperature, transport conditions, and rejection criteria. This matrix can be incorporated into electronic ordering systems, collection manuals, and staff training materials.

Purchasing teams should involve laboratory medicine, phlebotomy leadership, nursing, supply-chain management, infection prevention, information technology, and finance. A tube that works well in the central laboratory may create problems in an emergency department or remote draw station. Input from all collection and testing locations makes the final decision more reliable.

Final Guidance

The best blood collection tube for a plasma sample is the one that matches the test method, preserves the analyte, supports the required processing time, and performs reliably within the laboratory’s equipment and Supply Chain. For most routine chemistry applications, lithium-Heparin tubes are a strong default. Sodium Citrate is the appropriate choice for coagulation studies, while K2EDTA is commonly selected for many molecular and specialized plasma tests. Fluoride-containing and proprietary stabilization tubes have narrower but important roles.

Because tube colors and formulations vary, U.S. purchasers should verify product specifications, FDA-related documentation, manufacturer instructions, laboratory accreditation expectations, and assay-specific requirements. A structured validation process and total-cost analysis will usually produce a better result than choosing the least expensive tube or standardizing on one tube for every test.

Ultimately, reliable plasma testing begins before the specimen reaches the analyzer. Correct tube selection, accurate filling, gentle mixing, prompt processing, appropriate storage, and dependable inventory management work together to protect result quality and patient care.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos